Pharmaceutical Research & Mfg is categorized under Wholesale Pharmaceutical Products in Washington, DC .
Pharmaceutical Research & Mfg was established in 0, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number by the NAICS.
If you are seeking more information, feel free to contact Sangeetha Periyasamy at the company’s single location by writing to 950 F Street NW # 300, Washington, District of Columbia DC 20004 or by phoning (202) 835-3401. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Pharmaceutical Research & Mfg |
| Contact Person: | Sangeetha Periyasamy |
| Address: | 950 F Street NW # 300, Washington, District of Columbia 20004 |
| Phone Number: | (202) 835-3401 |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| Share This Business: |
Pharmaceutical Research & Mfg was started in 0 to provide professional Wholesale Pharmaceutical Products under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Sangeetha Periyasamy for inquiries that concern Pharmaceutical Research & Mfg by calling the company number (202) 835-3401, as your correspondence is most welcome. Additionally, the physical location of the single location of Pharmaceutical Research & Mfg can be found at the coordinates 38.89731,-77.02497 as well as the street address 950 F Street NW # 300 in Washington, District of Columbia 20004.
For its online presence, you may visit Pharmaceutical Research & Mfg’s website at and engage with its social media outlets through on Twitter and on Facebook.